GRCL
Gracell Biotechnologies Inc.
485.20$
-2.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| – | – | – | – | -100.0% | – | |
| – | – | – | – | – | – | |
| – | +128.2% | +41.6% | +93.6% | +48.5% | -8.4% | |
| – | +166.7% | +66.5% | +200.8% | +1.6% | -3.6% | |
| – | +134.5% | +46.3% | +116.4% | +34.6% | -7.3% | |
| – | – | – | – | – | – | |
| – | – | – | +134.9% | +33.1% | -4.4% | |
| – | – | – | – | – | – | |
| – | -479.2% | – | – | -99.8% | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.